SCHEMBL6119123

SCHEMBL6119123

[CH2][C@]12CC[C@@H](C(=C)COC)[C@@H]1[C@H]1CC[C@@H]3[C@@]4(C)CC[C@H](c5nccn5C(=O)O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC10A1 Q14973 1/20 0.40
▸ NT5E P21589 6/20 0.39
▸ PTPN1 P18031 4/20 0.39
▸ GPBAR1 Q8TDU6 3/20 0.39
▸ RORC P51449 2/20 0.39
▸ USP2 O75604 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ AKR1B10 O60218 1/20 0.39
▸ ALB P02768 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ GLI1 P08151 1/20 0.39
▸ AKR1B1 P15121 1/20 0.39
▸ DPP4 P27487 1/20 0.39
▸ SAE1 Q9UBE0 1/20 0.39
▸ UBA2 Q9UBT2 1/20 0.39
▸ PTGES O14684 2/20 0.39
▸ PRKCG P05129 2/20 0.39
▸ CES2 O00748 1/20 0.38
▸ TOP2A P11388 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6119088 0.89 RORC (0.50) NT5EPTPN1GPBAR1RORCUSP2
SCHEMBL6112771 0.86 SLC10A1 (0.40) SLC10A1NT5EPTPN1GPBAR1RORC
SCHEMBL6119240 0.82 SLC10A1 (0.40) SLC10A1NT5EPTPN1GPBAR1RORC
SCHEMBL3797717 0.80 NT5E (0.61) SLC10A1NT5EPTPN1GPBAR1RORC
SCHEMBL3797721 0.80 NT5E (0.61) SLC10A1NT5EPTPN1GPBAR1RORC
SCHEMBL6112792 0.80 PTPN1 (0.51) SLC10A1NT5EPTPN1GPBAR1RORC
SCHEMBL6112790 0.80 PTPN1 (0.51) SLC10A1NT5EPTPN1GPBAR1RORC
SCHEMBL3791454 0.79 SLC10A1 (0.57) SLC10A1NT5EPTPN1USP2LMNA
SCHEMBL3791455 0.79 SLC10A1 (0.57) SLC10A1NT5EPTPN1USP2LMNA
SCHEMBL3791751 0.76 RORC (0.52) NT5EPTPN1GPBAR1RORCUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8969395-B2 Triterpenoid derivatives useful as antiproliferative agents UNIVERSIDADE DE COIMBRA (PT) 2015-03-03 — — US disclosed
US-20120129901-A1 TRITERPENOID DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS UNIVERSIDADE DE COIMBRA (PT) 2012-05-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120129901-A1 TRITERPENOID DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS ALPI, LSS, CYP46A1 SLC10A1 43/4885NT5E 4541/4885PTPN1 3105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback